These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19221516)

  • 1. Towards development of stable formulations of a live attenuated bacterial vaccine: a preformulation study facilitated by a biophysical approach.
    Zeng Y; Fan H; Chiueh G; Pham B; Martin R; Lechuga-Ballesteros D; Truong VL; Joshi SB; Middaugh CR
    Hum Vaccin; 2009 May; 5(5):322-31. PubMed ID: 19221516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the stability of live oral attenuated bacterial vaccines.
    Cryz SJ; Pasteris O; Varallyay SJ; Fürer E
    Dev Biol Stand; 1996; 87():277-81. PubMed ID: 8854028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.
    Ohtake S; Martin R; Saxena A; Pham B; Chiueh G; Osorio M; Kopecko D; Xu D; Lechuga-Ballesteros D; Truong-Le V
    Vaccine; 2011 Mar; 29(15):2761-71. PubMed ID: 21300096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of measles virus for vaccine formulation.
    Kissmann J; Ausar SF; Rudolph A; Braun C; Cape SP; Sievers RE; Federspiel MJ; Joshi SB; Middaugh CR
    Hum Vaccin; 2008; 4(5):350-9. PubMed ID: 18382143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
    Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
    Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.
    Robbe-Saule V; Norel F
    FEMS Microbiol Lett; 1999 Jan; 170(1):141-3. PubMed ID: 9919662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 12. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
    Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the thermal stability of a novel strain of live-attenuated mumps vaccine (RS-12 strain) lyophilized in different stabilizers.
    Jamil RK; Taqavian M; Sadigh ZA; Shahkarami MK; Esna-Ashari F; Hamkar R; Hosseini SM; Hatami A
    J Virol Methods; 2014 Apr; 199():35-8. PubMed ID: 24462846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax vaccine powder formulations for nasal mucosal delivery.
    Jiang G; Joshi SB; Peek LJ; Brandau DT; Huang J; Ferriter MS; Woodley WD; Ford BM; Mar KD; Mikszta JA; Hwang CR; Ulrich R; Harvey NG; Middaugh CR; Sullivan VJ
    J Pharm Sci; 2006 Jan; 95(1):80-96. PubMed ID: 16315230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses.
    Robbe-Saule V; Coynault C; Norel F
    FEMS Microbiol Lett; 1995 Feb; 126(2):171-6. PubMed ID: 7705608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.